Hormonal replacement therapy in adolescents and young women with chemo- or radio-induced premature ovarian insufficiency: Practical recommendations.
Bone mineral density
Childhood cancer survivors
Hematopoietic stem cell transplantation
Hormone replacement therapy
Iatrogenic premature ovarian insufficiency
Puberty induction
Journal
Blood reviews
ISSN: 1532-1681
Titre abrégé: Blood Rev
Pays: England
ID NLM: 8708558
Informations de publication
Date de publication:
01 2021
01 2021
Historique:
received:
02
04
2020
revised:
10
05
2020
accepted:
23
06
2020
pubmed:
14
7
2020
medline:
4
9
2021
entrez:
14
7
2020
Statut:
ppublish
Résumé
In women with premature ovarian insufficiency (POI), hormonal therapy (HT) is indicated to decrease the risk of morbidity and to treat symptoms related to prolonged hypoestrogenism. While general recommendations for the management of HT in adults with POI have been published, no systematic suggestions focused on girls, adolescents and young women with POI following gonadotoxic treatments (chemotherapy, radiotherapy, stem cell transplantation) administered for pediatric cancer are available. In order to highlight the challenging issues specifically involving this cohort of patients and to provide clinicians with the proposal of practical therapeutic protocol, we revised the available literature in the light of the shared experience of a multidisciplinary team of pediatric oncologists, gynecologists and endocrinologists. We hereby present the proposals of a practical scheme to induce puberty in prepubertal girls and a decisional algorithm that should guide the clinician in approaching HT in post-pubertal adolescents and young women with iatrogenic POI.
Identifiants
pubmed: 32654893
pii: S0268-960X(20)30080-1
doi: 10.1016/j.blre.2020.100730
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
100730Informations de copyright
Copyright © 2020 Elsevier Ltd. All rights reserved.